Biotechnology Stocks I Performance Guide: Ginkgo Bioworks Holdings, Inc. (DNA)
DNA has no dividends.
Table and Chart of DNA Performance
See what a $1,000 investment in DNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DNA Returns | |
|---|---|
| Start Date | May-28-2021 |
| Start Price | $394.80 |
| End Date | Sep-19-2024 |
| End Price | $8.31 |
| # Prices | 41 |
| Min Date | Aug-30-2024 |
| Min Price | $6.69 |
| Max Date | Oct-29-2021 |
| Max Price | $552.80 |
| Total Return | -97.90% |
| Annualized Return | -67.70% |
| Current Value of $1,000 Purchase | $21 |
| Number Returns | 820 |
| Average Return | -54.11% |
| Number Profitable Returns | 76 |
| Percent Profitable Returns | 9.27% |
| Number Unprofitable Returns | 744 |
| Percent Unprofitable Returns | 90.73% |
| Profitable to Unprofitable Returns Ratio | 0.10 |
| DNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -1.792 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -633689024 |
| PE to Growth Ratio | None |
| Price to Book | 2.505 |
| PRICE DATA | |
| 52 Week High | $1.069 |
| 52 Week Low | $82.8 |
| Analyst Target Price | $-0.302 |
| 50-Day Moving Average | $5.26 |
| 200-Day Moving Average | $9.83 |
| FINANCIAL DATA | |
| Revenue per Share | $-18 |
| Revenue | $-1 |
| Profit Margin | 369.2% |
| Return on Equity | -22.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DNA Compare Returns with S&P 500
DNA Trendline Chart
DNA Moving Average Chart
DNA Stock Return Map - See Patterns of Gains and Losses
DNA Stock Returns/Purchase Dates